Champion Homes stock gets a Perform rating from Oppenheimer

Published on 10/05/2026 at 11:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Champion Homes stock drew a Perform initiation from Oppenheimer on September 30, 2026, with valuation and execution shaping the debate. Fiscal Q1 sales reached USD 710.2 million.

SKY, US8308301055, Illustration mit AI erstellt.

Champion Homes stock (ISIN US8308301055) was last at USD 88.10 on the NYSE on October 2, 2026, up 0.71 percent from the prior close. The latest analyst action came from Oppenheimer, which initiated coverage at Perform on September 30, 2026, putting valuation and execution at the center of the case.

Oppenheimer weighs valuation and execution

According to Investing.com on September 30, 2026, Oppenheimer cited the manufactured-housing backdrop, rising backlog, underutilized capacity and Champion Homes' expanding captive retail platform. The firm also said its estimates were below consensus and that margin recovery still requires stronger volume and execution.

The valuation argument is concrete. Investing.com reported a price-to-earnings ratio of 25.39 and described the risk and reward as balanced at current levels, while the October 2 price stood at USD 88.10.

Fiscal Q1 brings modest sales growth

Champion Homes reported fiscal Q1 2027 net sales of USD 710.2 million for the quarter ended June 27, 2026, an increase of 1.3 percent from fiscal Q1 2026. The company also reported a backlog of USD 421.8 million, gross profit margin of 25.2 percent, GAAP diluted EPS of USD 0.89 and adjusted EPS of USD 0.88, according to Business Wire.

The figures show the tension in the setup: revenue growth was positive, but Oppenheimer's comments make volume and execution the conditions for a broader margin recovery. The backlog provides a quantified demand reference, while the 25.2 percent gross margin supplies the operating benchmark for the next report.

Stock remains below its yearly high

At USD 88.10 on October 2, 2026, Champion Homes was USD 11.07 below its 52-week high of USD 99.17 and USD 24.41 above its 52-week low of USD 63.69. The NYSE-listed company had a market capitalization of USD 4.8 billion and trading volume of 368,838 shares on that date.

The market is therefore weighing incremental sales growth against the execution needed to convert backlog and retail expansion into stronger margins. For investors, the next test is whether operating improvement can move beyond the USD 710.2 million quarterly sales base.